Scarica l'app Stockscreener
0.88
1.38%
0.012
Dopo l'orario di chiusura:
.90
0.02
+2.27%
Precedente Chiudi:
$0.868
Aprire:
$0.86
Volume 24 ore:
74,067
Relative Volume:
0.42
Capitalizzazione di mercato:
$53.65M
Reddito:
-
Utile/perdita netta:
$-112.67M
Rapporto P/E:
-0.4513
EPS:
-1.95
Flusso di cassa netto:
$-79.26M
1 W Prestazione:
+13.24%
1M Prestazione:
-6.38%
6M Prestazione:
-8.81%
1 anno Prestazione:
-19.27%
Intervallo 1D:
$0.85
$0.90
Intervallo di 1 settimana:
$0.77
$0.92
Portata 52W:
$0.69
$1.60
Kronos Bio Inc Stock (KRON) Company Profile
Nome
Kronos Bio Inc
Settore
Industria
Telefono
(650) 781-5200
Indirizzo
1300 S. EL CAMINO REAL, SAN MATEO
Confronta KRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRON
Kronos Bio Inc
|
0.88 | 53.65M | 0 | -112.67M | -79.26M | -1.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.89 | 124.91B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.28 | 60.05B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
587.59 | 35.88B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.50 | 29.83B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
228.14 | 24.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Kronos Bio Inc Stock (KRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-14 | Downgrade | TD Cowen | Buy → Hold |
| 2022-09-14 | Iniziato | Berenberg | Buy |
| 2021-10-20 | Ripresa | Cowen | Outperform |
| 2021-06-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-03 | Iniziato | Cowen | Outperform |
| 2020-11-03 | Iniziato | Goldman | Buy |
| 2020-11-03 | Iniziato | Jefferies | Buy |
| 2020-11-03 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Kronos Bio Inc Borsa (KRON) Ultime notizie
Kronos Bio ends lease early, pays $1.4 million settlement By Investing.com - Investing.com South Africa
Kronos Bio Announces Lease Termination Agreement - TipRanks
Kronos Bio ends lease early, pays $1.4 million settlement - Investing.com
Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors - The Manila Times
Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace
Kronos Bio Reports 2024 Financial Results - TipRanks
Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail
Kronos Bio Full Year 2024 Earnings: US$1.43 loss per share (vs US$1.95 loss in FY 2023) - Yahoo Finance
Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Kronos Bio earnings missed by $0.17, revenue fell short of estimates - Investing.com Canada
Kronos Bio Inc (KRON) Q4 2024 Earnings: EPS Misses at -$0.43, Re - GuruFocus.com
Kronos Bio, Inc. SEC 10-K Report - TradingView
China Revives Its Carbon Credit Market: Price Swings & Future Outlook - The Globe and Mail
Navigating the U.S. Planting Season with Enhanced Risk Management - The Globe and Mail
Shootin' the Bull about cattle feeders - The Globe and Mail
KRONOS BIO Earnings Preview: Recent $KRON Insider Trading, Hedge Fund Activity, and More - Nasdaq
Kronos Bio (KRON) to Release Quarterly Earnings on Thursday - Defense World
Kronos Bio Insider Ups Holding By 36% During Year - Yahoo Finance
Kronos Bio, Inc. (NASDAQ:KRON) Shares Sold by Partners Capital Investment Group LLP - MarketBeat
Peapod Lane Capital LLC Purchases New Position in Kronos Bio, Inc. (NASDAQ:KRON) - MarketBeat
Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN
Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat
We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance
Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World
Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat
Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia
Kronos Bio ends partnership with Genentech - Investing.com India
Kronos Bio Ends Collaboration with Genentech and Roche - TipRanks
Kronos Bio (NASDAQ:KRON) Trading 8.5% HigherHere's Why - MarketBeat
Kronos Bio Inc Azioni (KRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Kronos Bio Inc Azioni (KRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 28 '24 |
Buy |
1.25 |
204,670 |
254,957 |
10,802,138 |
| BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 10 '24 |
Buy |
0.88 |
1,378,901 |
1,208,469 |
5,749,395 |
| BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 12 '24 |
Buy |
1.24 |
881,913 |
1,096,041 |
7,375,616 |
| BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 11 '24 |
Buy |
1.09 |
744,308 |
814,571 |
6,493,703 |
0.21%
1.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):